GABA Supplement Market Projected to See the Gummies Formulation Category Capture Dominant Retail Sales of US$ 28 Million
According to a specialized industrial analytics report published by Fact.MR, the global GABA supplement market is valued at USD 51.2 million in 2024. Driven by a widespread increase in modern, high-stress lifestyles, a rising global prevalence of insomnia and anxiety disorders, and an active preference for non-habit-forming relaxation aids, the industry is projected to reach a milestone valuation of USD 90.2 million by the close of 2034. International nutraceutical developers, functional food formulators, and dietary supplement brands are aggressively expanding production channels to meet a significant rise in consumer demand for natural cognitive wellness solutions. Moving past traditional over-the-counter sleep aids, the health and wellness sector is increasingly prioritizing gamma-aminobutyric acid (GABA) supplements—a primary inhibitory neurotransmitter known for regulating nervous system excitability and inducing physical relaxation. This targeted marketplace expansion rep...